nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparative analysis of paediatric dose-finding trials of molecularly targeted agent with adults’ trials
|
Paoletti, Xavier |
|
2013 |
49 |
10 |
p. 2392-2402 11 p. |
artikel |
2 |
A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer
|
Bahassi, El Mustapha |
|
2013 |
49 |
10 |
p. 2345-2355 11 p. |
artikel |
3 |
Diabetes mellitus as an independent risk factor for lung cancer: A meta-analysis of observational studies
|
Lee, Jung-Yun |
|
2013 |
49 |
10 |
p. 2411-2423 13 p. |
artikel |
4 |
Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: A report from the Children’s Oncology Group
|
Goldsby, Robert E. |
|
2013 |
49 |
10 |
p. 2384-2391 8 p. |
artikel |
5 |
Genetic deletion of the long isoform of the von Hippel–Lindau tumour suppressor gene product alters microtubule dynamics
|
Frew, Ian J. |
|
2013 |
49 |
10 |
p. 2433-2440 8 p. |
artikel |
6 |
German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer
|
|
|
2013 |
49 |
10 |
p. 2277-2283 7 p. |
artikel |
7 |
High pretreatment serum lactate dehydrogenase level correlates with disease relapse and predicts an inferior outcome in locally advanced nasopharyngeal carcinoma
|
Wan, Xiang-bo |
|
2013 |
49 |
10 |
p. 2356-2364 9 p. |
artikel |
8 |
KRAS mutations are associated with inferior clinical outcome in patients with metastatic colorectal cancer, but are not predictive for benefit with cediranib
|
Smith, John C. |
|
2013 |
49 |
10 |
p. 2424-2432 9 p. |
artikel |
9 |
Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer
|
Gannon, Philippe O. |
|
2013 |
49 |
10 |
p. 2441-2448 8 p. |
artikel |
10 |
Modern multidisciplinary treatment of rectal cancer based on staging with magnetic resonance imaging leads to excellent local control, but distant control remains a challenge
|
Engelen, S.M.E. |
|
2013 |
49 |
10 |
p. 2311-2320 10 p. |
artikel |
11 |
Neoadjuvant chemotherapy with paclitaxel and everolimus in breast cancer patients with non-responsive tumours to epirubicin/cyclophosphamide (EC)±bevacizumab – Results of the randomised GeparQuinto study (GBG 44)
|
Huober, Jens |
|
2013 |
49 |
10 |
p. 2284-2293 10 p. |
artikel |
12 |
Ovarian cancer: Ion channel and aquaporin expression as novel targets of clinical potential
|
Frede, Julia |
|
2013 |
49 |
10 |
p. 2331-2344 14 p. |
artikel |
13 |
Protein modelling of a novel KIT mutation (N567Y) in the gastrointestinal stromal tumour
|
Alyuruk, Hakan |
|
2013 |
49 |
10 |
p. 2449-2452 4 p. |
artikel |
14 |
Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial
|
Blamey, R.W. |
|
2013 |
49 |
10 |
p. 2294-2302 9 p. |
artikel |
15 |
Response to chemotherapy of solitary fibrous tumour: A retrospective study
|
Stacchiotti, S. |
|
2013 |
49 |
10 |
p. 2376-2383 8 p. |
artikel |
16 |
Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: A systematic review and meta-analysis
|
Flohil, Sophie C. |
|
2013 |
49 |
10 |
p. 2365-2375 11 p. |
artikel |
17 |
Smad7 and its evolving role as a prognostic marker in gastro-intestinal malignancies
|
Kapoor, Shailendra |
|
2013 |
49 |
10 |
p. 2453-2454 2 p. |
artikel |
18 |
The impact of epithelial–mesenchymal transition on R1 status of the mesopancreatic resection margin after pancreaticoduodenectomy for pancreatic carcinoma: A research proposal topic
|
Peparini, Nadia |
|
2013 |
49 |
10 |
p. 2455-2457 3 p. |
artikel |
19 |
Time trends in survival from cancer of unknown primary: Small steps forward
|
Riihimäki, M. |
|
2013 |
49 |
10 |
p. 2403-2410 8 p. |
artikel |
20 |
Tumour budding is a strong and independent prognostic factor in pancreatic cancer. Reply to Comment
|
Karamitopoulou, Eva |
|
2013 |
49 |
10 |
p. 2458-2459 2 p. |
artikel |
21 |
Use of raltitrexed as an alternative to 5-fluorouracil and capecitabine in cancer patients with cardiac history
|
Kelly, Claire |
|
2013 |
49 |
10 |
p. 2303-2310 8 p. |
artikel |
22 |
What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
|
van Dam, L. |
|
2013 |
49 |
10 |
p. 2321-2330 10 p. |
artikel |